Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Launched by RONALD MYERS · Dec 23, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how providing education and support can help increase lung cancer screenings for patients who have a history of smoking. Early screenings can catch lung cancer sooner, making it easier to treat. The trial aims to see if giving information and counseling to both healthcare providers and patients can encourage more people to get screened for lung cancer.
To be part of this study, you need to be between 50 and 77 years old, have a significant history of smoking (like smoking for many years), and either still smoke or have quit in the last 15 years. You should also have an upcoming appointment with a primary care provider at one of the participating health practices. If you join, you can expect to receive helpful information about lung cancer screening and its importance. This trial is currently recruiting participants, and it’s open to anyone who meets the criteria, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * PRACTICE LEVEL:
- • Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
- • Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
- • Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
- * PATIENT LEVEL:
- • Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days
- • 50 to 77 years of age
- • Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment)
- • Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment)
- • Able to communicate in English or Spanish (determined at baseline eligibility assessment)
- Exclusion Criteria:
- * PATIENT OUTREACH:
- • Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows
- • G0297 - LDCT screening
- • 71250 - CT w/o contrast
- • 71260 - CT w/ contrast
- • 71270 - CT with and w/o contrast
- • 71275 - CT angiography chest
- • 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh
- • 78816 - PET CT whole body
- • Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment)
- • Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment)
- • Dementia (diagnosis codes F03.90 or F03.91) in EHR
About Ronald Myers
Ronald Myers is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on ethical practices and rigorous scientific methodologies, Mr. Myers leads initiatives that explore new therapeutic options across various therapeutic areas. His extensive experience in clinical development, coupled with a passion for patient-centered care, positions him as a key contributor to the advancement of healthcare. By fostering collaboration among researchers, healthcare professionals, and regulatory bodies, Ronald Myers aims to facilitate the efficient translation of research findings into tangible benefits for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials